Remicov Injection 5 mg/ml contains Remdesivir, an antiviral medication used for the treatment of COVID-19 in hospitalized patients with moderate to severe disease. Remdesivir is a nucleotide analog prodrug that inhibits viral RNA-dependent RNA polymerase, thereby preventing viral replication. Administered intravenously, Remicov is particularly effective in reducing viral load, improving recovery time, and preventing progression to severe respiratory complications in patients infected with SARS-CoV-2.

This injection is designed for hospital use, ensuring controlled administration and precise dosing. Remdesivir has shown clinical benefits in patients requiring supplemental oxygen, supporting faster clinical improvement, and reducing the need for mechanical ventilation in severe COVID-19 cases.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Composition

Each milliliter of Remicov Injection contains:

• Remdesivir 5 mg

Indications

Remicov Injection 5 mg/ml is indicated for:

• Treatment of COVID-19 in adults and pediatric patients (≥12 years and ≥40 kg) requiring hospitalization

• Management of patients with moderate to severe COVID-19 infection, including those on supplemental oxygen

• Shortening time to clinical recovery in hospitalized patients

• Reducing the risk of progression to severe disease in high-risk patients

Mechanism of Action

Remdesivir acts by:

• Being metabolized to its active nucleoside triphosphate form inside cells

• Inhibiting RNA-dependent RNA polymerase, an enzyme critical for viral replication

• Causing premature termination of viral RNA chains, preventing virus proliferation

• Supporting the immune system in controlling viral infection and reducing disease severity

This targeted mechanism allows Remdesivir to act specifically against SARS-CoV-2 without affecting human DNA replication.

Dosage and Administration

• Remicov Injection is administered intravenously under medical supervision.

• Typical dosing for adults:

  • Day 1 (loading dose): 200 mg IV over 30–120 minutes

  • Day 2 onwards (maintenance dose): 100 mg IV once daily for 5–10 days, depending on clinical response

• Pediatric dosing is adjusted according to body weight and clinical condition.

• The infusion should be prepared using aseptic technique and administered via compatible IV fluids.

• Monitor liver and kidney function before and during therapy to ensure safe use.

Precautions and Warnings

• Use with caution in patients with renal impairment (eGFR <30 mL/min) or liver dysfunction.

• Monitor liver enzymes and renal function during treatment.

• Not recommended for patients with hypersensitivity to Remdesivir or any excipients.

• Avoid co-administration with nephrotoxic or hepatotoxic drugs without proper monitoring.

• Pregnancy and breastfeeding: use only if benefits outweigh risks, under medical supervision.

Possible Side Effects

Remicov Injection is generally well tolerated. Common side effects include:

• Nausea

• Headache

• Elevated liver enzymes

• Hypersensitivity reactions at the infusion site

Serious but rare side effects may include:

• Severe hypersensitivity or anaphylactic reactions

• Liver injury or hepatotoxicity

• Acute kidney injury

Immediate medical attention is required for severe reactions or unexpected symptoms.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Storage Instructions

• Store below 30°C in a cool, dry place.

• Protect from light and moisture.

• Do not freeze.

• Keep out of reach of children.

Conclusion

Remicov Injection 5 mg/ml (Remdesivir) is a critical antiviral therapy for hospitalized patients with moderate to severe COVID-19. Its targeted action against SARS-CoV-2 supports faster recovery, reduces disease progression, and improves clinical outcomes when used under strict medical supervision.